BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study
Open Access
- 12 April 2022
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (7), 1028-1035
- https://doi.org/10.1136/annrheumdis-2021-221824
Abstract
Introduction Emerging evidence supports the immunogenic response to mRNA COVID-19 vaccine in patients with autoimmune rheumatic diseases (ARD). However, large-scale data about the association between vaccination, and COVID-19 outcomes in patients with ARD is limited. Methods We used data from Clalit Health Services, which covers more than half of the population in Israel. Patients with ARD older than 18 were included between 20 December 2021 and 30 September 2021, when the BNT162b2 mRNA COVID-19 vaccine, and later a third booster dose, were available. The primary outcome was a documented positive SARS-CoV-2 PCR test. We used a Cox regression models with vaccination status as time-dependent covariate and calculated the HR for the study outcome. Results We included 127 928 patients with ARD, of whom, by the end of the study follow-up, there were 27 350 (21.3%) unvaccinated patients, 31 407 (24.5%) vaccinated patients and 69 171 (54.1%) patients who also received a third booster-dose. We identified 8470 (6.6%) patients with a positive SARS-CoV-2 PCR test during the study period. The HR for SARS-CoV-2 infection among the vaccination group was 0.143 (0.095 to 0.214, pConclusion Our results indicate that both the BNT162b2 mRNA COVID-19 vaccine and the booster are associated with better COVID-19 outcomes in patients with ARD.This publication has 39 references indexed in Scilit:
- Rising opioid prescription fulfillment among non-cancer and non-elderly patients—Israel’s alarming exampleRegional Anesthesia & Pain Medicine, 2020
- Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature reviewSeminars in Arthritis and Rheumatism, 2020
- Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseasesAnnals Of The Rheumatic Diseases, 2020
- Three handy tips and a practical guide to improve your propensity score modelsRMD Open, 2019
- Epidemiology of axial spondyloarthritis: an updateCurrent Opinion in Rheumatology, 2018
- The epidemiology of psoriatic arthritis in Israel – a population-based studyArthritis Research & Therapy, 2018
- The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations.2007
- Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA studyAnnals Of The Rheumatic Diseases, 2005
- The prevalence of rheumatoid arthritis in the general population of SpainRheumatology, 2002
- Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RAAnnals Of The Rheumatic Diseases, 2001